Chlormet CEO Yari Nieken talks to Cantech Letter

Warning message

The subscription service is currently unavailable. Please try again later.

When Chlormet Technologies (CSE:PUF) acquired AAA Heidelberg, a company in the process of applying for an Marihuana for Medical Purposes Regulations (MMPR) license with Heath Canada it already had a partially completed 8800 square foot marijuana cultivation facility in London, Ontario. Soon after, Chlormet added a facility for production and processing of marijuana in Washington State.

But CEO and co-founder Yari Nieken, while optimistic about the multi-billion dollar opportunity in the medical marijuana space, was also a realist. Nieken knew that the company had exposed itself to a tangle of bureaucracy it simply could not control. Under the Marijuana for Medical Purposes Regulations (MMPR), Health Canada no longer supplies marijuana to those with a proven medical need but instead has tasked licensed commercial producers to do so. Currently, 22 companies hold 26 licenses to produce marijuana in Canada. Many more are expected to be added, but the timeline is uncertain.

So Nieken...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.